Updated Jul 16, 2026
Bejar Rafael has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Bejar Rafael is listed in Aptose Biosciences Inc.'s SEC filings as of 2026-07-01. Public biographical information tying this exact name to Aptose beyond the SEC filing is limited, and the precise role (e.g., director, officer, or consultant) is not disclosed in widely available sources. The available context confirms an association with Aptose Biosciences, but does not provide a detailed career history or background. No obituary is known in connection with this name as of the filing date.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-01 | APTO | Aptose Biosciences Inc. | D — Derivative transaction | 244 | $1.72 | $420 |
Bejar Rafael is listed in Aptose Biosciences Inc.'s SEC filings as of 2026-07-01. Public biographical information tying this exact name to Aptose beyond the SEC filing is limited, and the precise role (e.g., director, officer, or consultant) is not disclosed in widely available sources. The available context confirms an association with Aptose Biosciences, but does not provide …
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Bejar Rafael profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.